Acupuncture for Prevention of Postoperative Nausea and Vomiting (PONV)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04866121 |
|
Recruitment Status :
Recruiting
First Posted : April 29, 2021
Last Update Posted : May 3, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| PONV | Procedure: Acupuncture | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 105 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Triple (Care Provider, Investigator, Outcomes Assessor) |
| Primary Purpose: | Prevention |
| Official Title: | The Comparison of P6+ST36 Combination Acupuncture Therapy With P6 Alone Acupuncture and Standard Treatment in Postoperative Nausea and Vomiting |
| Actual Study Start Date : | May 1, 2021 |
| Estimated Primary Completion Date : | May 1, 2022 |
| Estimated Study Completion Date : | May 1, 2022 |
| Arm | Intervention/treatment |
|---|---|
|
No Intervention: Standard Treatment
Following 8 hours fasting, standard anesthesia protocol, 3 mg kg-1 Propofol, 0.6 mg kg-1 rocuronium and 2 µg kg-1 fentanyl will be administered. Laparoscopic cholecystectomy will be performed. Twenty minutes prior to the completion of the operation tramadol 100mg will be administered for analgesia.
|
|
|
Active Comparator: Single point (P6) Acupuncture
Prior to the anesthesia induction, the same certified medical doctor will perform a standard acupuncture protocol to the P6 point bilaterally. For P6 acupuncture stimulation 0,25x25mm steel needles will be immersed for 2cm. For stimulation, the needles will be turned clock-wise 3 times. This stimulation will be repeated for 3 times with 10 seconds intervals. The needles will be held in place for 20 minutes and will be removed afterwards. Following 8 hours fasting, standard anesthesia protocol, 3 mg kg-1 Propofol, 0.6 mg kg-1 rocuronium and 2 µg kg-1 fentanyl will be administered. Laparoscopic cholecystectomy will be performed. Twenty minutes prior to the completion of the operation tramadol 100mg will be administered for analgesia. |
Procedure: Acupuncture
A standardized acupuncture protocol will be administered |
|
Experimental: Double point (P6+ST36) Acupuncture
Prior to the anesthesia induction, the same certified medical doctor will perform a standard acupuncture protocol both to the P6 and ST36 points bilaterally. For P6 acupuncture stimulation 0,25x25mm steel needles will be immersed for 2cm. For ST6 acupuncture stimulation 0,25x50mm steel needles will be immersed for 5cm. For stimulation, the needles will be turned clock-wise 3 times. This stimulation will be repeated for 3 times with 10 seconds intervals. The needles will be held in place for 20 minutes and will be removed afterwards. Following 8 hours fasting, standard anesthesia protocol, 3 mg kg-1 Propofol, 0.6 mg kg-1 rocuronium and 2 µg kg-1 fentanyl will be administered. Laparoscopic cholecystectomy will be performed. Twenty minutes prior to the completion of the operation tramadol 100mg will be administered for analgesia.
|
Procedure: Acupuncture
A standardized acupuncture protocol will be administered |
- PONV prophylaxis [ Time Frame: 12 months ]The frequency of PONV development
- Postoperative anti-emetic requirement [ Time Frame: 12 months ]The amount of anti-emetic agent administered postoperatively
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | Laparoscopic cholecystectomy is performed far more in women than in men with a ratio of 5:1. Additionally, being women is one of the major risk factors for PONV development. |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Women between 18-65 years old, who have ASA scores of I-II-III and who are planned to undergo elective laparoscopic cholecystectomy.
Exclusion Criteria:
- Pregnant women
- Lactating women
- Women with steel hypersensitivity
- Mental retarded patients
- Patients with psychological disorders and neurologic sequel
- Additionally, patients who;
- have nausea/vomiting, consume anti-emetic or emetogenic drugs, alcohol, opioid drugs, glucocorticoid drug and have acupuncture treatment for any reason 72 hours prior to surgery
- have skin reactions at the site of acupuncture application
- had intraoperative gangrenous cholecystitis, gall bladder perforation, malignant pathological outcome
- were admitted to intensive care unite
- had to convert to open surgery will be excluded.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04866121
| Contact: Alirıza Erdoğan, MD | 05333558377 | alirizaerdogan@ohu.edu.tr |
| Turkey | |
| Niğde Ömer Halisdemir University Training and Research Hospital | Recruiting |
| Niğde, Turkey | |
| Contact: Alirıza Erdoğan, MD 05333558377 alirizaerdogan@ohu.edu.tr | |
| Responsible Party: | Alirıza Erdoğan, Principal Investigator, Nigde Omer Halisdemir University |
| ClinicalTrials.gov Identifier: | NCT04866121 |
| Other Study ID Numbers: |
14.04.2021/28 |
| First Posted: | April 29, 2021 Key Record Dates |
| Last Update Posted: | May 3, 2021 |
| Last Verified: | April 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
PONV P6 Acupuncture ST36 Acupuncture |
|
Vomiting Postoperative Nausea and Vomiting Nausea |
Signs and Symptoms, Digestive Postoperative Complications Pathologic Processes |

